VanEck Morningstar SMID Moat ETF (SMOT)
BATS: SMOT · Real-Time Price · USD
41.27
+0.41 (1.00%)
Aug 21, 2026, 4:00 PM EDT - Market closed
1.00% (1D)
| Assets | $333.90M |
| Expense Ratio | 0.49% |
| PE Ratio | 21.01 |
| Shares Out | 8.13M |
| Dividend (ttm) | $0.50 |
| Dividend Yield | 1.21% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 25.32% |
| Volume | 18,958 |
| Open | 41.12 |
| Previous Close | 40.86 |
| Day's Range | 41.08 - 41.29 |
| 52-Week Low | 34.25 |
| 52-Week High | 41.32 |
| Beta | 1.09 |
| Holdings | 111 |
| Inception Date | Oct 4, 2022 |
About SMOT
Fund Home PageThe VanEck Morningstar SMID Moat ETF (SMOT) is an exchange-traded fund that mostly invests in extended market equity. The fund tracks an index made up of two equally-weighted sub-portfolios, comprised of small- and mid-cap companies believed to have durable competitive advantages and attractive valuations. SMOT was launched on Oct 4, 2022 and is issued by VanEck.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange BATS
Ticker Symbol SMOT
ETF Provider VanEck
Index Tracked Morningstar US Small-Mid Cap Moat Focus
Top 10 Holdings
15.14% of assets| Name | Symbol | Weight |
|---|---|---|
| IQVIA Holdings Inc. | IQV | 1.63% |
| Airbnb, Inc. | ABNB | 1.63% |
| Bio-Techne Corporation | TECH | 1.63% |
| Acuity Inc. | AYI | 1.56% |
| BioMarin Pharmaceutical Inc. | BMRN | 1.46% |
| Lamb Weston Holdings, Inc. | LW | 1.46% |
| Royalty Pharma plc | RPRX | 1.46% |
| Stifel Financial Corp. | SF | 1.45% |
| Becton, Dickinson and Company | BDX | 1.43% |
| Amcor plc | AMCR | 1.43% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $0.4975 | Dec 26, 2025 |
| Dec 23, 2024 | $0.4082 | Dec 24, 2024 |
| Dec 18, 2023 | $0.2055 | Dec 22, 2023 |
| Dec 19, 2022 | $0.0644 | Dec 23, 2022 |
Performance
SMOT had a total return of 16.99% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.57%.
News
VanEck Expands Moat Investing Suite With Launch of ETF Targeting Small- and Mid-Cap Moat Stocks
NEW YORK--(BUSINESS WIRE)--VanEck adds SMOT to moat-focused ETF lineup at a time when small-/mid-cap valuations are at 20-year lows relative to large caps.
4 years ago - Business Wire